Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
P 1 (1)

Trial Status

Recruiting2
Withdrawn1

Clinical Trials (3)

Showing 3 of 3 trials
NCT06717048Not ApplicableRecruiting

Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression

NCT06625749Not ApplicableRecruiting

Evaluate the Safety and Effectiveness of the AccuraSee™ IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery

NCT00348166Phase 1WithdrawnPrimary

Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten Children?

Showing all 3 trials

Research Network

Activity Timeline